Baltimore, MDNCT06089980Now EnrollingIRB Ready

Kratom Pharmacokinetics Clinical Trial in Baltimore, MD

Access cutting-edge kratom pharmacokinetics treatment through this clinical trial at a research site in Baltimore. Study-provided care at no cost to qualified participants.

Sponsored by Johns Hopkins University

Quick Self-Assessment

See if you qualify for this Baltimore location

Preparing your pre-screening questions…

Expert Care in Baltimore

Access kratom pharmacokinetics specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related kratom pharmacokinetics treatment provided free

Apply for This Baltimore Location

Check if you qualify for this kratom pharmacokinetics clinical trial in Baltimore, MD

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Baltimore

    Convenient for MD residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Baltimore site if eligible
  4. 4Begin participation

About This Kratom Pharmacokinetics Study in Baltimore

The goal of this observational clinical study is to is to learn more about how commercial kratom products affect healthy adults who consume them regularly. The main questions it aims to answer are: 1. What are the acute physiological, subjective, and cognitive effects of kratom following participant self-administration of a single oral dose of the participants usual kratom product at the participants typical dose? 2. What are the physiological, subjective, and cognitive effects associated with kratom product discontinuation among adults who use regularly? 3. What are the pharmacokinetics of kratom products consumed by adults who use regularly? On the first study day: Under direct observation, participants will self-administer a single oral dose of the participants own commercial kratom product that that is regularly taken and will consume it at the participants self-selected typical dose/serving. Following this, serial blood draws and urine collection will occur along with administration of validated questionnaires, tests, and continual monitoring. After this first study day, participants will no longer be permitted to use any of the participants kratom product during the study. On study nights/days 2-3: participants will reside a clinical research unit and be observed and evaluated for kratom withdrawal syndrome.

Sponsor: Johns Hopkins University

Who Can Participate

Inclusion Criteria

reporting kratom use \>5 times per week for \>3 months prior to study screening
English language proficiency
Willingness to provide requested samples of the kratom product being currently taken

Exclusion Criteria

Reports any acute adverse, unexpected, or otherwise sudden health event related to the typical kratom product dose that occurred within 30 days of screening
Having ever sought medical attention for an acute adverse health event as a result of taking any kratom product.
Cannot or will not provide kratom product samples in the form of an unopened package of kratom that is clearly labeled with at least the product and vendor name.
Self-reports using kratom products by any other route than orally swallowing.
Current physical dependence on alcohol, benzodiazepines, or opioids
Reports use of fentanyl within the past month and/or has a fentanyl positive drug screen.
Discordance between self-reported substance use and drug screen results obtained during screening.
Lifetime or current psychotic disorder
Current untreated major depressive or bipolar disorder
Pregnancy or nursing
Physical, psychiatric, or environmental conditions considered by study team to increase risk or undue burden (e.g., untreated hypertension, high BMI, etc.).

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Baltimore?

Yes, this clinical trial (NCT06089980) has an active research site in Baltimore, MD that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Kratom Pharmacokinetics Treatment Options in Baltimore, MD

If you're searching for kratom pharmacokinetics treatment options in Baltimore, MD, this clinical trial (NCT06089980) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Baltimore research site is actively enrolling participants for this clinical trial. You'll receive care from experienced kratom pharmacokinetics specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all kratom pharmacokinetics clinical trials near you to find additional studies recruiting in your area.

More Neuroendocrine Tumors Trials in Baltimore, MD

See all neuroendocrine tumors clinical trials recruiting in Baltimore — not just this study.

Browse Neuroendocrine Tumors Trials in Baltimore

Ready to Join in Baltimore?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Baltimore, MD